Status:
COMPLETED
The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury
Lead Sponsor:
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions:
Spinal Cord Injuries
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Aim 1: Determine the neurophysiologic impact of Transcutaneous Spinal Cord Stimulation (TSCS) within a single session. The investigators hypothesize that subjects will demonstrate increased volitional...
Eligibility Criteria
Inclusion
- 18-65 years old
- \>1 year post SCI
- Non-progressive SCI
- Neurological level above T10
- Tolerates upright position for \>30 minutes
- Medically stable (no hospitalizations in last 3 months)
- Able to comply with procedures and follow up
- Are legally able to make their own health care decisions
Exclusion
- Progressive SCI/D (MS, ALS, ADEM, etc.)
- Open wounds at stimulation site
- Pregnant women
- ROM limitations impacting gait training
- Cardiac pacemaker/defibrillator
- Active cancer diagnosis
- Currently receiving TSCS
- Evidence of uncontrolled autonomic dysreflexia
- Non-English speaking subjects will not be targeted
Key Trial Info
Start Date :
January 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03384017
Start Date
January 5 2017
End Date
October 28 2020
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rebecca Martin, OTR/L, OTD, CPAM
Baltimore, Maryland, United States, 21205